Interacting Drugs |
Ketorolac (systemic) vs Eplerenone |
Security Level |
 |
Mechanism |
Eplerenone: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Eplerenone. Nonsteroidal Anti-Inflammatory Agents may enhance the hyperkalemic effect of Eplerenone. |
Management |
Monitor therapy |
Ketorolac (systemic) vs Eplerenone
Post Review about Ketorolac (systemic) vs Eplerenone Click here to cancel reply.
Other Interactions of Ketorolac (systemic)
Other Interactions of Eplerenone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.